Markus Ponleitner

440 total citations
34 papers, 230 citations indexed

About

Markus Ponleitner is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Markus Ponleitner has authored 34 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 6 papers in Molecular Biology. Recurrent topics in Markus Ponleitner's work include Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (6 papers) and Polyomavirus and related diseases (6 papers). Markus Ponleitner is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (6 papers) and Polyomavirus and related diseases (6 papers). Markus Ponleitner collaborates with scholars based in Austria, Germany and United Kingdom. Markus Ponleitner's co-authors include Paulus Rommer, Patrick Altmann, Thomas Berger, Fritz Leutmezer, Gabriel Bsteh, Axel Petzold, Henrik Zetterberg, Raphael Wurm, Heidemarie Zach and Patrick Mucher and has published in prestigious journals such as Nature Communications, Neurology and Scientific Reports.

In The Last Decade

Markus Ponleitner

26 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Ponleitner Austria 8 96 65 51 38 35 34 230
Tjalf Ziemssen Germany 9 58 0.6× 53 0.8× 66 1.3× 12 0.3× 33 0.9× 26 237
Osheik Seidi United Kingdom 10 132 1.4× 66 1.0× 127 2.5× 25 0.7× 11 0.3× 17 360
Ömer Faruk Turan Türkiye 9 84 0.9× 27 0.4× 41 0.8× 42 1.1× 10 0.3× 36 229
V. Deburghgraeve France 7 158 1.6× 115 1.8× 31 0.6× 11 0.3× 7 0.2× 13 237
Nadia Tenenbaum United States 11 234 2.4× 90 1.4× 80 1.6× 8 0.2× 42 1.2× 21 369
Qi‐Lun Lai China 11 27 0.3× 162 2.5× 62 1.2× 9 0.2× 24 0.7× 37 295
Teresa Ayuso Spain 9 128 1.3× 122 1.9× 43 0.8× 4 0.1× 20 0.6× 22 250
Lily Jung Henson United States 7 87 0.9× 51 0.8× 63 1.2× 6 0.2× 14 0.4× 12 222
Aria Setoodeh Iran 13 37 0.4× 30 0.5× 140 2.7× 22 0.6× 64 1.8× 44 414
Robert A Bermel United States 7 271 2.8× 124 1.9× 36 0.7× 8 0.2× 12 0.3× 12 349

Countries citing papers authored by Markus Ponleitner

Since Specialization
Citations

This map shows the geographic impact of Markus Ponleitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Ponleitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Ponleitner more than expected).

Fields of papers citing papers by Markus Ponleitner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Ponleitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Ponleitner. The network helps show where Markus Ponleitner may publish in the future.

Co-authorship network of co-authors of Markus Ponleitner

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Ponleitner. A scholar is included among the top collaborators of Markus Ponleitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Ponleitner. Markus Ponleitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berek, Klaus, Michael Auer, Franziska Di Pauli, et al.. (2025). Impact of renal function impairment on kappa free light chain index. Clinical Chemistry and Laboratory Medicine (CCLM). 63(9). 1792–1799. 2 indexed citations
2.
Bsteh, Gabriel, Harald Hegen, Nik Krajnc, et al.. (2025). Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis. Neurology. 105(8). e214069–e214069.
3.
Ponleitner, Markus, Nik Krajnc, Tobias Zrzavy, et al.. (2025). Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR). Journal of Neurology. 272(12). 774–774.
4.
Aigner, Christof, et al.. (2024). Pregnancy outcomes of Fabry disease in Austria (PROFABIA)-a retrospective cohort-study. Orphanet Journal of Rare Diseases. 19(1). 165–165. 2 indexed citations
5.
Ponleitner, Markus, Gabriel Bsteh, Jakob Rath, et al.. (2024). Investigation of serum neurofilament light chain as a biomarker in Fabry disease. Scientific Reports. 14(1). 23033–23033. 1 indexed citations
6.
Wurm, Raphael, Suriya Prausmüller, Markus Ponleitner, et al.. (2024). Serum Markers of Neurodegeneration Are Strongly Linked to Heart Failure Severity and Outcome. JACC Heart Failure. 12(6). 1073–1085. 7 indexed citations
7.
Berek, Klaus, Anna Lindner, Franziska Di Pauli, et al.. (2024). Neurofilament Light Chain Is Associated With Acute Mountain Sickness. Brain and Behavior. 14(11). e70165–e70165. 1 indexed citations
8.
Krajnc, Nik, Fritz Leutmezer, Markus Ponleitner, et al.. (2024). Autoimmune screening panel in patients with multiple sclerosis: A Vienna multiple sclerosis database study. European Journal of Neurology. 32(1). e16558–e16558.
9.
Beitzke, Dietrich, Senta Graf, Max Lenz, et al.. (2023). Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease. Life. 13(5). 1213–1213. 10 indexed citations
10.
Ponleitner, Markus, Yoshiki Takai, Daniel Hofmann, et al.. (2023). Paths to hippocampal damage in neuromyelitis optica spectrum disorders. Neuropathology and Applied Neurobiology. 49(2). e12893–e12893. 3 indexed citations
11.
Zierfuss, Bettina, Violetta Zujovic, Petra Waidhofer‐Söllner, et al.. (2023). Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders. Biomolecules. 13(12). 1696–1696. 5 indexed citations
12.
Ponleitner, Markus, Manfred Hecking, Senta Graf, et al.. (2023). Phenotyping of a novel COL4A4 and novel GLA variant in a patient presenting with microhematuria and mildly impaired kidney function: a case report. Frontiers in Genetics. 14. 1211858–1211858.
13.
Zulehner, Gudrun, Christian Schörgenhofer, Paulus Rommer, et al.. (2023). Serum neurofilament light chain as an early diagnostic biomarker for critical illness polyneuropathy. Minerva Anestesiologica. 89(12). 1099–1104. 3 indexed citations
14.
Zrzavy, Tobias, Markus Ponleitner, Patrick Altmann, et al.. (2023). Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). Journal of Neurology. 270(8). 3779–3786. 4 indexed citations
15.
Hegen, Harald, Klaus Berek, Gabriel Bsteh, et al.. (2023). Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study. EBioMedicine. 91. 104573–104573. 17 indexed citations
16.
Altmann, Patrick, Fritz Leutmezer, Markus Ponleitner, et al.. (2021). The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study. JMIR Research Protocols. 10(5). e25011–e25011. 3 indexed citations
17.
Altmann, Patrick, Markus Ponleitner, Paulus Rommer, et al.. (2021). Seven day pre-analytical stability of serum and plasma neurofilament light chain. Scientific Reports. 11(1). 11034–11034. 43 indexed citations
18.
Ponleitner, Markus, Dániel Szöllősi, Ali El‐Kasaby, et al.. (2021). Thermal Unfolding of the Human Serotonin Transporter: Differential Effect by Stabilizing and Destabilizing Mutations and Cholesterol on Thermodynamic and Kinetic Stability. Molecular Pharmacology. 101(2). 95–105. 9 indexed citations
19.
Altmann, Patrick, Katharina Leithner, Fritz Leutmezer, et al.. (2021). Sexuality and Multiple Sclerosis: Patient and Doctor Perspectives. The Journal of Sexual Medicine. 18(4). 743–749. 10 indexed citations
20.
Dal‐Bianco, Assunta, Günther Grabner, Gisela Pußwald, et al.. (2021). Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study. Frontiers in Neurology. 12. 632749–632749. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tjalf Ziemssen Breakdown of academic impact, for papers by Osheik Seidi Breakdown of academic impact, for papers by Ömer Faruk Turan Breakdown of academic impact, for papers by V. Deburghgraeve Breakdown of academic impact, for papers by Nadia Tenenbaum Breakdown of academic impact, for papers by Qi‐Lun Lai Breakdown of academic impact, for papers by Teresa Ayuso Breakdown of academic impact, for papers by Lily Jung Henson Breakdown of academic impact, for papers by Aria Setoodeh Breakdown of academic impact, for papers by Robert A Bermel
Rankless by CCL
2026